Skip to main content
Fig. 4 | Cancer Imaging

Fig. 4

From: Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: diagnostic performance and outcomes using biparametric vs. multiparametric MRI

Fig. 4

Fifty-five-year old woman with high grade muscle-invasive urothelial bladder cancer on transurethral resection. MRI performed after 4 cycles of neoadjuvant gemcitabine + carboplatin, showed an intermediate signal nodule (arrow) on T2-weighted imaging (A) with corresponding focal high signal on diffusion-weighed imaging (B) and early and strong enhancement on post-contrast MRI (C). At radical cystectomy, there was residual tumor with perivesical fat invasion (ypT3). Tumor recurred at the pelvic sidewall at 78 days after surgery and the patient subsequently died at 128 days after surgery

Back to article page